(Q53482870)

English

Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice.

scientific article published on 18 April 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

Vaccination of fiber-modified adenovirus-transfected dendritic cells to express HER-2/neu stimulates efficient HER-2/neu-specific humoral and CTL responses and reduces breast carcinogenesis in transgenic mice. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

S Sas

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

T Chan

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

A Sami

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

A El-Gayed

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

J Xiang

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

publication date

18 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

Cancer Gene Therapy

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

15

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

10

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

655-666

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

https://scigraph.springernature.com/pub.10.1038/cgt.2008.18

0 references

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

The cell biology of antigen presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Identification and characterization of the immunodominant rat HER-2/neu MHC class I epitope presented by spontaneous mammary tumors from HER-2/neu-transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

The life span of major histocompatibility complex-peptide complexes influences the efficiency of presentation and immunogenicity of two class I-restricted cytotoxic T lymphocyte epitopes in the Epstein-Barr virus nuclear antigen 4

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

In vivo CTL induction with point-substituted ovalbumin peptides: immunogenicity correlates with peptide-induced MHC class I stability

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Th1 and Th2 cell clones to a poorly immunogenic tumor antigen initiate CD8+ T cell-dependent tumor eradication in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

The generation of both T killer and Th cell clones specific for the tumor-associated antigen HER2 using retrovirally transduced dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Targeting HER-2/neu in early breast cancer development using dendritic cells with staged interleukin-12 burst secretion.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Dendritic cells can be rapidly expanded ex vivo and safely administered in patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Vaccination by genetically modified dendritic cells expressing a truncated neu oncogene prevents development of breast cancer in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

HER-2/neu-gene engineered dendritic cell vaccine stimulates stronger HER-2/neu-specific immune responses compared to DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Efficient gene delivery into dendritic cells by fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

An adenoviral vector containing an arg-gly-asp (RGD) motif in the fiber knob enhances protein product levels from transgenes refractory to expression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

A simplified system for generating recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Conditionally replication-competent adenoviral vectors with enhanced infectivity for use in gene therapy of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

A new dynamic model of CD8+ T effector cell responses via CD4+ T helper-antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Regression of engineered tumor cells secreting cytokines is related to a shift in host cytokine profile from type 2 to type 1.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Progress and potential for gene-based medicines

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Gene therapy. Second child in French trial is found to have leukemia

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Cell receptors involved in adenovirus entry

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Maturation of dendritic cells infected by recombinant adenovirus can be delayed without impact on transgene expression

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination.

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Anti-HER-2/neu immune responses are induced before the development of clinical tumors but declined following tumorigenesis in HER-2/neu transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

21 January 2018

neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Presentation of a major histocompatibility complex class 1-binding peptide by monocyte-derived dendritic cells incorporating hydrophobized polysaccharide-truncated HER2 protein complex: implications for a polyvalent immuno-cell therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Vaccination of advanced hepatocellular carcinoma patients with tumor lysate-pulsed dendritic cells: a clinical trial

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced HER-2/neu-specific antitumor immunity by cotransduction of mouse dendritic cells with two genes encoding HER-2/neu and alpha tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus-mediated TNF-alpha gene transfer induces significant tumor regression in mice

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Adenovirus vectors for high-efficiency gene transfer into mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Upregulation of integrins alpha v beta 3 and alpha v beta 5 on human monocytes and T lymphocytes facilitates adenovirus-mediated gene delivery

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/CGT.2008.18

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/18421311

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53482870&oldid=1959640191"